Ascendis Pharma A/S (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Ascendis Pharma A/S - ADR: Is Infosys Ltd. worth buying?
Item: Ascendis Pharma A/S - ADR
Rating: 1.61225
Author: Trendlyne DVM scores

about

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, a...

205.83 -9.21 (-4.28%)

74.39% Gain from 52W Low

693.1K

XNAS Volume

XNAS 16 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

5.5 / 100

Technically Neutral

59.0 / 100

263

1Yr Price target upside is 28%

15 analysts

Ascendis Pharma A/S (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..